-
INTEGRATING PRESCRIBING, HOSPITAL ACTIVITY AND POPULATION SEGMENTATION: A UNIFIED VIEW OF MEDICINES VALUE ACROSS THE NATIONAL HEALTH SERVICE (NHS) ENGLAND
Aug 11, 2026, 17:15 PM -
COST-EFFECTIVENESS ANALYSIS OF VILLAGE IN A DISH AS A PHARMACOGENOMIC TEST TO PREDICT TREATMENT OUTCOMES OF RILUZOLE VERSUS EDARAVONE FOR AMYOTROPHIC LATERAL SCLEROSIS PATIENTS
Aug 11, 2026, 17:15 PM -
ECONOMIC EVALUATION OF CONTINUOUSGLUCOSE MONITORING DEVICES VERSUS SMBG FOR TYPE 1 DIABETIC CHILDREN IN EGYPT FROM A SOCIETAL PERSPECTIVE
Aug 11, 2026, 17:15 PM -
OVERDOSE EARLY WARNING SYSTEMS: KEY LIMITATIONS AND POTENTIAL ALTERNATIVE APPROACHES
Aug 11, 2026, 17:15 PM -
VALUE OF TELEMONITORING FOR POSITIVE AIRWAY PRESSURE THERAPY MANAGEMENT IN OBSTRUCTIVE SLEEP APNEA: A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:15 PM -
COST-CONSEQUENCE ANALYSIS OF HIGH-EFFICACY DISEASE-MODIFYING THERAPIES IN RELAPSING-REMITTING MULTIPLE SCLEROSIS PATIENTS WITH COMORBIDITY BURDEN IN SPAIN
Aug 11, 2026, 17:15 PM -
HEALTH STATE UTILITIES ASSOCIATED WITH OTOFERLIN-RELATED HEARING LOSS
Aug 11, 2026, 17:15 PM -
WHEN ONE MAIC BECOMES ONE TOO MANY: MULTIPLICITY AND EVIDENCE INTERPRETATION IN THE EU JOINT CLINICAL ASSESSMENT CONTEXT
Aug 11, 2026, 17:15 PM -
WHEN EVIDENCE FAILS TO CHANGE DECISIONS: THE MISSING LINK BETWEEN MEASUREMENT AND VALUE IN HEALTHCARE
Aug 11, 2026, 17:15 PM -
REPORTING FIDELITY OF PRIMARY ENDPOINTS IN FDA-APPROVED NSCLC THERAPIES: AN EXTENSION OF THE COMPARE METHOD
Aug 11, 2026, 17:15 PM -
EVALUATION OF USE OF OVERALL SURVIVAL AS CO-PRIMARY OR SECONDARY ENDPOINT IN CROSSOVER TRIALS: A SYSTEMATIC LITERATURE REVIEW OF HEALTH TECHNOLOGY ASSESSMENT (HTA) SUBMISSIONS OF TREATMENTS FOR SELECT TUMORS IN ONCOLOGY
Aug 11, 2026, 17:15 PM -
METHODOLOGICAL APPROACHES TO HEALTH ECONOMIC EVALUATIONS OF PREP STRATEGIES: A LITERATURE REVIEW
Aug 11, 2026, 17:15 PM -
GREY AREAS: DOES GREY LITERATURE BELONG IN EVERY SLR?
Aug 11, 2026, 17:15 PM -
THE IMPACT OF A COMMUNITY HEALTH WORKER INTERVENTION VERSUS USUAL CARE ON HEALTHCARE UTILIZATION AMONG PEOPLE WITH UNMET HEALTH NEEDS IN BELGIUM: A MIXED METHODS STUDY
Aug 11, 2026, 17:15 PM -
EVALUATING THE ECONOMIC IMPACT OF EARLIER CAR T USE IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A 24-MONTH COST SEQUENCING ANALYSIS FROM THE BRAZILIAN PRIVATE HEALTHCARE PERSPECTIVE
Aug 11, 2026, 17:15 PM -
PROSPECTIVE AI-ENABLED PICO PREDICTION FOR EU JOINT CLINICAL ASSESSMENT: BLINDED VALIDATION USING THE FIRST PUBLISHED JCA REPORT ON TOVORAFENIB
Aug 11, 2026, 17:15 PM -
COMPARISON OF NAIVE VERSUS DELAYED-ENTRY ADJUSTMENT METHODS IN REAL-WORLD SURVIVAL ANALYSIS OF FIRST-LINE METASTATIC NSCLC WITH PD-L1 TPS =50%
Aug 11, 2026, 17:15 PM -
EVALUATING FULLY AUTOMATED FULL-TEXT SCREENING FOR HTA SYSTEMATIC REVIEWS
Aug 11, 2026, 17:15 PM -
FROM MECHANISM TO VALUE: A STRATEGIC FRAMEWORK FOR EARLY ECONOMIC MODELING OF DISEASE-MODIFYING THERAPIES ACROSS THE DEVELOPMENT LIFECYCLE
Aug 11, 2026, 17:15 PM -
HIGH-FREQUENCY PROMS WITH INTEGRATION INTO ELECTRONIC HEALTH RECORDS: A NOVEL CLINICAL OUTCOME
Aug 11, 2026, 17:15 PM
